PhytoHealth Corp 
Welcome,         Profile    Billing    Logout  
 5 Products   11 Diseases  5 Products   1 Trial   51 News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
astragalus polysaccharides  (PG2) / PhytoHealth Corp
NCT05440227: PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

Recruiting
2
36
RoW
PG2 Lyo. Injection 500mg, Placebo 0.9% normal saline
PhytoHealth Corporation
Cancer-related Fatigue
12/25
06/26
PH-CP028, NCT03611712: PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer

Completed
2
48
RoW
Astragalus Polysaccharides 500 mg, PG2 Lyo. Injection 500 mg
PhytoHealth Corporation
Cancer-related Fatigue, Survival, Tumor, Esophageal
02/23
03/25
PHN014 / PhytoHealth Corp
No trials found
PHN015 / PhytoHealth Corp
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
astragalus polysaccharides  (PG2) / PhytoHealth Corp
NCT05440227: PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

Recruiting
2
36
RoW
PG2 Lyo. Injection 500mg, Placebo 0.9% normal saline
PhytoHealth Corporation
Cancer-related Fatigue
12/25
06/26
PH-CP028, NCT03611712: PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer

Completed
2
48
RoW
Astragalus Polysaccharides 500 mg, PG2 Lyo. Injection 500 mg
PhytoHealth Corporation
Cancer-related Fatigue, Survival, Tumor, Esophageal
02/23
03/25
PHN014 / PhytoHealth Corp
No trials found
PHN015 / PhytoHealth Corp
No trials found

Download Options